Clinical Trial Update: A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis [Phase 4]

View source ↗

Summary

This Phase 4 trial compared ligation plus nadolol versus nadolol alone to prevent the first variceal bleed in cirrhosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Variceal Bleeding

Drugs mentioned

• Nadolol (Nadolol)

Snippet

Sponsor: National Science and Technology Council, Taiwan | Conditions: Variceal Bleeding, Cirrhosis | Phase 4 | Status: COMPLETED